Principal Investigators
Esbensen, Anna, PhD
About
Despite a higher risk of Attention Deficit Hyperactivity Disorder (ADHD) among children with Down syndrome (DS), rates of stimulant medication treatment are disproportionately low. We are conducting the first randomized clinical trial (RCT) of stimulant medication in children with DS+ADHD to provide evidence regarding the short- and long-term safety and efficacy of stimulant use in children with DS+ADHD, both with and without CHD. All children enrolled in the study will complete a comprehensive assessment battery evaluating ADHD diagnostic criteria as well as behavioral, cognitive, academic, and functional impairments.